Although such enhancement processes have not been described for SARS-CoV-2 in human vaccinees, typical features of VAERD have been observed in TH2-biased mice vaccinated with alum-adjuvanted whole-inactivated virus or S protein upon subsequent infection with mouse-adapted SARS-CoV-213,14. This evidence concerns the gene PROS1 and infection.